Puma Biotechnology, Inc. (PBYI)
Puma Biotechnology Market Cap : 311.36M for March 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Assertio Holdings, Inc. | 85.79M |
| Rigel Pharmaceuticals, Inc. | 479.56M |
| Ironwood Pharmaceuticals, Inc. | 495.70M |
| AbbVie, Inc. | 362.60B |
| Phathom Pharmaceuticals, Inc. | 883.33M |
Market Cap Related Metrics
| PE Ratio | 10.02 |
| PS Ratio | 1.357 |
| PEG Ratio | 101.90 |
| Price to Book Value | 2.389 |
| Price to Free Cash Flow | 7.424 |
| Price | 6.12 |
| Earnings Yield | 9.98% |
| PEGY Ratio | 101.90 |
| Operating PE Ratio | 8.307 |
| Normalized PE Ratio | 10.02 |